A dual potassium channel activator improves repolarization reserve and normalizes ventricular action potentials

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

A dual potassium channel activator improves repolarization reserve and normalizes ventricular action potentials. / Calloe, Kirstine; Di Diego, José M; Hansen, Rie Schultz; Nagle, Shea A; Treat, Jacqueline A; Cordeiro, Jonathan M.

In: Biochemical Pharmacology, Vol. 108, 19.03.2016, p. 36-46.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Calloe, K, Di Diego, JM, Hansen, RS, Nagle, SA, Treat, JA & Cordeiro, JM 2016, 'A dual potassium channel activator improves repolarization reserve and normalizes ventricular action potentials', Biochemical Pharmacology, vol. 108, pp. 36-46. https://doi.org/10.1016/j.bcp.2016.03.015

APA

Calloe, K., Di Diego, J. M., Hansen, R. S., Nagle, S. A., Treat, J. A., & Cordeiro, J. M. (2016). A dual potassium channel activator improves repolarization reserve and normalizes ventricular action potentials. Biochemical Pharmacology, 108, 36-46. https://doi.org/10.1016/j.bcp.2016.03.015

Vancouver

Calloe K, Di Diego JM, Hansen RS, Nagle SA, Treat JA, Cordeiro JM. A dual potassium channel activator improves repolarization reserve and normalizes ventricular action potentials. Biochemical Pharmacology. 2016 Mar 19;108:36-46. https://doi.org/10.1016/j.bcp.2016.03.015

Author

Calloe, Kirstine ; Di Diego, José M ; Hansen, Rie Schultz ; Nagle, Shea A ; Treat, Jacqueline A ; Cordeiro, Jonathan M. / A dual potassium channel activator improves repolarization reserve and normalizes ventricular action potentials. In: Biochemical Pharmacology. 2016 ; Vol. 108. pp. 36-46.

Bibtex

@article{2c4b3abcf28e48629b09b1a3e3b6f0a1,
title = "A dual potassium channel activator improves repolarization reserve and normalizes ventricular action potentials",
abstract = "BACKGROUND: A loss of repolarization reserve due to downregulation of K(+) currents has been observed in cultured ventricular myocytes. A similar reduction of K(+) currents is well documented under numerous pathophysiological conditions. We examined the extent of K(+) current downregulation in cultured canine cardiac myocytes and determined whether a dual K(+) current activator can normalize K(+) currents and restore action potential (AP) configuration.METHODS AND RESULTS: Ventricular myocytes were isolated and cultured for up to 48h. Current and voltage clamp recordings were made using patch electrodes. Application of NS3623 to coronary-perfused left ventricular wedges resulted in increased phase 1 magnitude, epicardial AP notch and J wave amplitude. Patch clamp measurements of IKr and Ito revealed an increase in the magnitude of both currents. Culturing of Mid ventricular cells resulted in a significant decrease in Ito and IKr density. NS3623 increased Ito from 16.4±2.23 to 31.8±4.5pA/pF, and IKr from 0.28±0.06 to 0.47±0.09pA/pF after 2days in culture. AP recordings from 2day cultured cells exhibited a reduced phase 1 repolarization, AP prolongation, and early afterdepolarizations (EADs). NS3623 restored the AP notch and was able to suppress EADs.CONCLUSIONS: NS3623 is a dual Ito and IKr activator. Application of this compound to cells with a reduced repolarization reserve resulted in an increase in these currents and a shortening of AP duration, increase in phase 1 repolarization and suppression of EADs. Our results suggest a potential benefit of K(+) current activators under conditions of reduced repolarization reserve including heart failure.",
author = "Kirstine Calloe and {Di Diego}, {Jos{\'e} M} and Hansen, {Rie Schultz} and Nagle, {Shea A} and Treat, {Jacqueline A} and Cordeiro, {Jonathan M}",
note = "Copyright {\textcopyright} 2016 Elsevier Inc. All rights reserved.",
year = "2016",
month = mar,
day = "19",
doi = "10.1016/j.bcp.2016.03.015",
language = "English",
volume = "108",
pages = "36--46",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - A dual potassium channel activator improves repolarization reserve and normalizes ventricular action potentials

AU - Calloe, Kirstine

AU - Di Diego, José M

AU - Hansen, Rie Schultz

AU - Nagle, Shea A

AU - Treat, Jacqueline A

AU - Cordeiro, Jonathan M

N1 - Copyright © 2016 Elsevier Inc. All rights reserved.

PY - 2016/3/19

Y1 - 2016/3/19

N2 - BACKGROUND: A loss of repolarization reserve due to downregulation of K(+) currents has been observed in cultured ventricular myocytes. A similar reduction of K(+) currents is well documented under numerous pathophysiological conditions. We examined the extent of K(+) current downregulation in cultured canine cardiac myocytes and determined whether a dual K(+) current activator can normalize K(+) currents and restore action potential (AP) configuration.METHODS AND RESULTS: Ventricular myocytes were isolated and cultured for up to 48h. Current and voltage clamp recordings were made using patch electrodes. Application of NS3623 to coronary-perfused left ventricular wedges resulted in increased phase 1 magnitude, epicardial AP notch and J wave amplitude. Patch clamp measurements of IKr and Ito revealed an increase in the magnitude of both currents. Culturing of Mid ventricular cells resulted in a significant decrease in Ito and IKr density. NS3623 increased Ito from 16.4±2.23 to 31.8±4.5pA/pF, and IKr from 0.28±0.06 to 0.47±0.09pA/pF after 2days in culture. AP recordings from 2day cultured cells exhibited a reduced phase 1 repolarization, AP prolongation, and early afterdepolarizations (EADs). NS3623 restored the AP notch and was able to suppress EADs.CONCLUSIONS: NS3623 is a dual Ito and IKr activator. Application of this compound to cells with a reduced repolarization reserve resulted in an increase in these currents and a shortening of AP duration, increase in phase 1 repolarization and suppression of EADs. Our results suggest a potential benefit of K(+) current activators under conditions of reduced repolarization reserve including heart failure.

AB - BACKGROUND: A loss of repolarization reserve due to downregulation of K(+) currents has been observed in cultured ventricular myocytes. A similar reduction of K(+) currents is well documented under numerous pathophysiological conditions. We examined the extent of K(+) current downregulation in cultured canine cardiac myocytes and determined whether a dual K(+) current activator can normalize K(+) currents and restore action potential (AP) configuration.METHODS AND RESULTS: Ventricular myocytes were isolated and cultured for up to 48h. Current and voltage clamp recordings were made using patch electrodes. Application of NS3623 to coronary-perfused left ventricular wedges resulted in increased phase 1 magnitude, epicardial AP notch and J wave amplitude. Patch clamp measurements of IKr and Ito revealed an increase in the magnitude of both currents. Culturing of Mid ventricular cells resulted in a significant decrease in Ito and IKr density. NS3623 increased Ito from 16.4±2.23 to 31.8±4.5pA/pF, and IKr from 0.28±0.06 to 0.47±0.09pA/pF after 2days in culture. AP recordings from 2day cultured cells exhibited a reduced phase 1 repolarization, AP prolongation, and early afterdepolarizations (EADs). NS3623 restored the AP notch and was able to suppress EADs.CONCLUSIONS: NS3623 is a dual Ito and IKr activator. Application of this compound to cells with a reduced repolarization reserve resulted in an increase in these currents and a shortening of AP duration, increase in phase 1 repolarization and suppression of EADs. Our results suggest a potential benefit of K(+) current activators under conditions of reduced repolarization reserve including heart failure.

U2 - 10.1016/j.bcp.2016.03.015

DO - 10.1016/j.bcp.2016.03.015

M3 - Journal article

C2 - 27002181

VL - 108

SP - 36

EP - 46

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

ER -

ID: 159675352